Bio-Techne Releases Third Quarter Fiscal 2021 Results

Go back to Bio-Techne Releases Third Quarter Fiscal 2021 Results

Bio-Techne (TECH) Tops Q3 EPS by 24c, Revenues Beat

May 6, 2021 6:33 AM EDT

Bio-Techne (NASDAQ: TECH) reported Q3 EPS of $1.79, $0.24 better than the analyst estimate of $1.55. Revenue for the quarter came in at $243.6 million versus the consensus estimate of $228.22 million.

"Congratulations to the entire global Bio-Techne team for delivering another consecutive record quarter," Said Chuck Kummeth, President and CEO... More